vs
Side-by-side financial comparison of NATIONAL RESEARCH CORP (NRC) and NETSTREIT Corp. (NTST). Click either name above to swap in a different company.
NETSTREIT Corp. is the larger business by last-quarter revenue ($57.1M vs $35.2M, roughly 1.6× NATIONAL RESEARCH CORP). NETSTREIT Corp. runs the higher net margin — 10.0% vs 5.1%, a 4.9% gap on every dollar of revenue. On growth, NETSTREIT Corp. posted the faster year-over-year revenue change (24.3% vs -4.6%). Over the past eight quarters, NETSTREIT Corp.'s revenue compounded faster (20.1% CAGR vs -0.2%).
National Research Corporation, doing business as NRC Health, is an American healthcare company which provides healthcare products and subscription-based solutions in United States and Canada. It was founded in 1981, and is based in Lincoln, Nebraska.
NETSTREIT Corp. is a US-headquartered real estate investment trust (REIT) that specializes in acquiring and operating a diversified portfolio of single-tenant net lease commercial properties. Its asset portfolio covers retail, industrial and office categories, primarily catering to investment-grade corporate tenants across the United States market.
NRC vs NTST — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $35.2M | $57.1M |
| Net Profit | $1.8M | $5.7M |
| Gross Margin | — | — |
| Operating Margin | 13.3% | 34.1% |
| Net Margin | 5.1% | 10.0% |
| Revenue YoY | -4.6% | 24.3% |
| Net Profit YoY | -72.6% | 235.9% |
| EPS (diluted) | $49.58 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $57.1M | ||
| Q4 25 | $35.2M | $52.5M | ||
| Q3 25 | $34.6M | $48.3M | ||
| Q2 25 | $34.0M | $48.3M | ||
| Q1 25 | $33.6M | $45.9M | ||
| Q4 24 | $36.9M | $44.1M | ||
| Q3 24 | $35.8M | $41.4M | ||
| Q2 24 | $35.0M | $39.6M |
| Q1 26 | — | $5.7M | ||
| Q4 25 | $1.8M | $1.3M | ||
| Q3 25 | $4.1M | $618.0K | ||
| Q2 25 | $-106.0K | $3.3M | ||
| Q1 25 | $5.8M | $1.7M | ||
| Q4 24 | $6.6M | $-5.4M | ||
| Q3 24 | $5.7M | $-5.3M | ||
| Q2 24 | $6.2M | $-2.3M |
| Q1 26 | — | 34.1% | ||
| Q4 25 | 13.3% | 2.6% | ||
| Q3 25 | 22.4% | 1.3% | ||
| Q2 25 | 4.7% | 6.8% | ||
| Q1 25 | 25.6% | 3.7% | ||
| Q4 24 | 26.0% | -12.3% | ||
| Q3 24 | 22.3% | -12.8% | ||
| Q2 24 | 25.3% | -5.8% |
| Q1 26 | — | 10.0% | ||
| Q4 25 | 5.1% | 2.5% | ||
| Q3 25 | 11.9% | 1.3% | ||
| Q2 25 | -0.3% | 6.8% | ||
| Q1 25 | 17.2% | 3.7% | ||
| Q4 24 | 17.8% | -12.3% | ||
| Q3 24 | 15.9% | -12.8% | ||
| Q2 24 | 17.6% | -5.8% |
| Q1 26 | — | $0.32 | ||
| Q4 25 | $49.58 | $0.01 | ||
| Q3 25 | $0.18 | $0.01 | ||
| Q2 25 | $-0.01 | $0.04 | ||
| Q1 25 | $0.25 | $0.02 | ||
| Q4 24 | $0.27 | $-0.07 | ||
| Q3 24 | $0.24 | $-0.07 | ||
| Q2 24 | $0.26 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.1M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $14.0M | $1.5B |
| Total Assets | $134.9M | $2.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $4.1M | — | ||
| Q3 25 | $2.2M | — | ||
| Q2 25 | $5.3M | — | ||
| Q1 25 | $2.5M | — | ||
| Q4 24 | $4.2M | — | ||
| Q3 24 | $3.5M | — | ||
| Q2 24 | $485.0K | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $1.1B | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $926.6M | ||
| Q1 25 | — | $913.3M | ||
| Q4 24 | — | $868.3M | ||
| Q3 24 | $48.7M | $778.7M | ||
| Q2 24 | $33.3M | $726.2M |
| Q1 26 | — | $1.5B | ||
| Q4 25 | $14.0M | $1.4B | ||
| Q3 25 | $14.3M | $1.3B | ||
| Q2 25 | $21.3M | $1.3B | ||
| Q1 25 | $29.7M | $1.3B | ||
| Q4 24 | $31.3M | $1.3B | ||
| Q3 24 | $34.6M | $1.3B | ||
| Q2 24 | $40.2M | $1.3B |
| Q1 26 | — | $2.8B | ||
| Q4 25 | $134.9M | $2.6B | ||
| Q3 25 | $135.7M | $2.5B | ||
| Q2 25 | $141.4M | $2.3B | ||
| Q1 25 | $135.2M | $2.3B | ||
| Q4 24 | $132.5M | $2.3B | ||
| Q3 24 | $131.8M | $2.2B | ||
| Q2 24 | $119.1M | $2.1B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.76× | ||
| Q3 25 | — | 0.84× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.70× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | 1.41× | 0.58× | ||
| Q2 24 | 0.83× | 0.55× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $7.2M | — |
| Free Cash FlowOCF − Capex | $6.1M | — |
| FCF MarginFCF / Revenue | 17.2% | — |
| Capex IntensityCapex / Revenue | 3.2% | — |
| Cash ConversionOCF / Net Profit | 3.99× | — |
| TTM Free Cash FlowTrailing 4 quarters | $15.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $7.2M | $109.5M | ||
| Q3 25 | $13.8M | $28.0M | ||
| Q2 25 | $-1.1M | $30.6M | ||
| Q1 25 | $6.6M | $22.1M | ||
| Q4 24 | $6.4M | $90.2M | ||
| Q3 24 | $9.4M | $25.1M | ||
| Q2 24 | $6.8M | $25.4M |
| Q1 26 | — | — | ||
| Q4 25 | $6.1M | — | ||
| Q3 25 | $10.2M | — | ||
| Q2 25 | $-4.1M | — | ||
| Q1 25 | $3.7M | — | ||
| Q4 24 | $1.9M | — | ||
| Q3 24 | $7.8M | — | ||
| Q2 24 | $1.5M | — |
| Q1 26 | — | — | ||
| Q4 25 | 17.2% | — | ||
| Q3 25 | 29.4% | — | ||
| Q2 25 | -12.2% | — | ||
| Q1 25 | 10.9% | — | ||
| Q4 24 | 5.2% | — | ||
| Q3 24 | 21.8% | — | ||
| Q2 24 | 4.3% | — |
| Q1 26 | — | — | ||
| Q4 25 | 3.2% | — | ||
| Q3 25 | 10.4% | — | ||
| Q2 25 | 8.8% | — | ||
| Q1 25 | 8.9% | — | ||
| Q4 24 | 12.0% | — | ||
| Q3 24 | 4.5% | — | ||
| Q2 24 | 15.0% | — |
| Q1 26 | — | — | ||
| Q4 25 | 3.99× | 82.46× | ||
| Q3 25 | 3.34× | 45.27× | ||
| Q2 25 | — | 9.36× | ||
| Q1 25 | 1.15× | 13.06× | ||
| Q4 24 | 0.97× | — | ||
| Q3 24 | 1.66× | — | ||
| Q2 24 | 1.10× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NRC
Segment breakdown not available.
NTST
| Rental revenue (including reimbursable) | $54.0M | 95% |
| Other | $3.0M | 5% |